company background image
ZTS logo

Zoetis NYSE:ZTS Stock Report

Last Price

US$192.39

Market Cap

US$87.3b

7D

2.7%

1Y

10.4%

Updated

15 Oct, 2024

Data

Company Financials +

ZTS Stock Overview

Engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally.

ZTS fundamental analysis
Snowflake Score
Valuation3/6
Future Growth2/6
Past Performance2/6
Financial Health4/6
Dividends4/6

Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

US$213.78
FV
10.0% undervalued intrinsic discount
6.45%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
6 days ago author updated this narrative

Zoetis Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Zoetis
Historical stock prices
Current Share PriceUS$192.39
52 Week HighUS$201.92
52 Week LowUS$144.80
Beta0.89
11 Month Change0.68%
3 Month Change5.68%
1 Year Change10.40%
33 Year Change-5.89%
5 Year Change56.66%
Change since IPO520.41%

Recent News & Updates

Recent updates

Zoetis: A Solid Choice For The Young Dividend Growth Investor

Oct 09

Do Zoetis' (NYSE:ZTS) Earnings Warrant Your Attention?

Oct 08
Do Zoetis' (NYSE:ZTS) Earnings Warrant Your Attention?

Zoetis: Investing In Pet Health And Portfolio Wealth

Sep 26

Are Investors Undervaluing Zoetis Inc. (NYSE:ZTS) By 23%?

Sep 20
Are Investors Undervaluing Zoetis Inc. (NYSE:ZTS) By 23%?

There's Reason For Concern Over Zoetis Inc.'s (NYSE:ZTS) Price

Aug 30
There's Reason For Concern Over Zoetis Inc.'s (NYSE:ZTS) Price

Zoetis: Librela Sales Should Peak 200-300% Above Management's $1B Target

Aug 13

Zoetis Q2 Earnings: Harvesting From DTC (Rating Upgrade)

Aug 07

Does Zoetis (NYSE:ZTS) Have A Healthy Balance Sheet?

Jul 16
Does Zoetis (NYSE:ZTS) Have A Healthy Balance Sheet?

Zoetis: A High-Quality Business And Fast Dividend Growth At A Reasonable Price

Jul 03

Zoetis: Don't Fret Excessively Over The Animal Healthcare Leader

Jun 11

A Look At The Intrinsic Value Of Zoetis Inc. (NYSE:ZTS)

Jun 10
A Look At The Intrinsic Value Of Zoetis Inc. (NYSE:ZTS)

Zoetis (NYSE:ZTS) Ticks All The Boxes When It Comes To Earnings Growth

May 23
Zoetis (NYSE:ZTS) Ticks All The Boxes When It Comes To Earnings Growth

Zoetis: Why The Focus On Companion Animal Segment Will Pay Off

May 22

The Zoetis Inc. (NYSE:ZTS) First-Quarter Results Are Out And Analysts Have Published New Forecasts

May 04
The Zoetis Inc. (NYSE:ZTS) First-Quarter Results Are Out And Analysts Have Published New Forecasts

Zoetis: Long-Term Buy Despite Safety Concerns

May 03

Despite Lawsuit Risks: Why Zoetis Remains A Compelling Investment

Apr 15

Zoetis Inc.'s (NYSE:ZTS) Shareholders Might Be Looking For Exit

Apr 12
Zoetis Inc.'s (NYSE:ZTS) Shareholders Might Be Looking For Exit

Zoetis: My Favorite Healthcare Stock Right Now

Mar 21

Estimating The Fair Value Of Zoetis Inc. (NYSE:ZTS)

Mar 03
Estimating The Fair Value Of Zoetis Inc. (NYSE:ZTS)

Zoetis: Buy This High-Quality Dividend Growth Beast On Weakness

Feb 27

Animal Kingdom's Ally: Zoetis And Its Path To 10%+ Returns

Jan 10

Some Confidence Is Lacking In Zoetis Inc.'s (NYSE:ZTS) P/E

Jan 01
Some Confidence Is Lacking In Zoetis Inc.'s (NYSE:ZTS) P/E

Zoetis' (NYSE:ZTS) Upcoming Dividend Will Be Larger Than Last Year's

Dec 14
Zoetis' (NYSE:ZTS) Upcoming Dividend Will Be Larger Than Last Year's

Does Zoetis (NYSE:ZTS) Have A Healthy Balance Sheet?

Dec 06
Does Zoetis (NYSE:ZTS) Have A Healthy Balance Sheet?

Here's Why We Think Zoetis (NYSE:ZTS) Might Deserve Your Attention Today

Nov 18
Here's Why We Think Zoetis (NYSE:ZTS) Might Deserve Your Attention Today

Zoetis: High-Quality Compounder With A Reasonable Price After Earnings

Nov 09

Zoetis: Significant CapEx Investments For Long-Term Growth, But A Hold Now

Oct 26

Zoetis Is An Impressive Healthcare Compounder

Sep 26

Estimating The Intrinsic Value Of Zoetis Inc. (NYSE:ZTS)

Sep 25
Estimating The Intrinsic Value Of Zoetis Inc. (NYSE:ZTS)

Here's Why Zoetis (NYSE:ZTS) Can Manage Its Debt Responsibly

Sep 04
Here's Why Zoetis (NYSE:ZTS) Can Manage Its Debt Responsibly

Zoetis: Pawses Pain, Librela OA Treatment Targets Furry Friends In The U.S.

Aug 22

Should You Be Adding Zoetis (NYSE:ZTS) To Your Watchlist Today?

Aug 12
Should You Be Adding Zoetis (NYSE:ZTS) To Your Watchlist Today?

Zoetis: My Dog Approves Of This Dividend Compounder

Jul 19

Zoetis: A Purrfect Addition To Your Portfolio

Jun 22

Does This Valuation Of Zoetis Inc. (NYSE:ZTS) Imply Investors Are Overpaying?

Jun 10
Does This Valuation Of Zoetis Inc. (NYSE:ZTS) Imply Investors Are Overpaying?

These 4 Measures Indicate That Zoetis (NYSE:ZTS) Is Using Debt Reasonably Well

Apr 16
These 4 Measures Indicate That Zoetis (NYSE:ZTS) Is Using Debt Reasonably Well

Estimating The Intrinsic Value Of Zoetis Inc. (NYSE:ZTS)

Mar 10
Estimating The Intrinsic Value Of Zoetis Inc. (NYSE:ZTS)

Zoetis rises on 2023 revenue forecast above estimates, Q4 profit in-line with consensus

Feb 14

Zoetis Is An Awesome Dividend Growth Stock

Jan 17

It's A Great Time To Buy Zoetis Shares

Jan 10

Shareholder Returns

ZTSUS PharmaceuticalsUS Market
7D2.7%2.0%1.5%
1Y10.4%19.0%33.1%

Return vs Industry: ZTS underperformed the US Pharmaceuticals industry which returned 19% over the past year.

Return vs Market: ZTS underperformed the US Market which returned 33.1% over the past year.

Price Volatility

Is ZTS's price volatile compared to industry and market?
ZTS volatility
ZTS Average Weekly Movement3.0%
Pharmaceuticals Industry Average Movement9.4%
Market Average Movement6.3%
10% most volatile stocks in US Market14.8%
10% least volatile stocks in US Market3.1%

Stable Share Price: ZTS has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: ZTS's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
195214,100Kristin Peckwww.zoetis.com

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives.

Zoetis Inc. Fundamentals Summary

How do Zoetis's earnings and revenue compare to its market cap?
ZTS fundamental statistics
Market capUS$87.28b
Earnings (TTM)US$2.34b
Revenue (TTM)US$8.92b

37.2x

P/E Ratio

9.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ZTS income statement (TTM)
RevenueUS$8.92b
Cost of RevenueUS$2.67b
Gross ProfitUS$6.24b
Other ExpensesUS$3.90b
EarningsUS$2.34b

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

Nov 04, 2024

Earnings per share (EPS)5.17
Gross Margin70.01%
Net Profit Margin26.29%
Debt/Equity Ratio132.9%

How did ZTS perform over the long term?

See historical performance and comparison

Dividends

0.9%

Current Dividend Yield

32%

Payout Ratio

Does ZTS pay a reliable dividends?

See ZTS dividend history and benchmarks
When do you need to buy ZTS by to receive an upcoming dividend?
Zoetis dividend dates
Ex Dividend DateOct 31 2024
Dividend Pay DateDec 03 2024
Days until Ex dividend15 days
Days until Dividend pay date48 days

Does ZTS pay a reliable dividends?

See ZTS dividend history and benchmarks